SLC5A5 and breast cancer: To demonstrate the efficacy of NIS gene-mediated radio-iodine therapy on in vivo orthotopic BC model, engineered ZR-75-1 cells overexpressing luciferase reporter (CMV-Fl2.Turbo) were used.